Medtronic plcMDT announced the receipt of FDA approval and commercial launch of its portfolio of Azure pacemakers with BlueSync technology. According to the company, this technology enables secure, ...
DUBLIN - November 20, 2017 - Medtronic plc (MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with ...
Azure pacemakers feature Medtronic-exclusive BlueSync technology, which enables automatic, secure wireless remote monitoring via the Medtronic CareLink(TM)Network, providing timely alerts of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results